Literature DB >> 2785663

Corticotropin-releasing factor synapses within the paraventricular nucleus of the hypothalamus.

A J Silverman1, A Hou-Yu, W P Chen.   

Abstract

Corticotropin-releasing factor (CRF) regulates the release of adrenocorticotropin (ACTH) from the anterior pituitary and these neurosecretory neurons reside in the paraventricular nucleus of the hypothalamus (PVN). In addition to its role as an ACTH secretogogue, exogenously administered CRF can act centrally to modify sympathetic outflow, alter various stress-induced behaviors and modulate its own secretion. Some of these effects might be mediated by CRF acting synaptically within the PVN as the nucleus is known to play a major role in integration of autonomic function. The current ultrastructural immunocytochemical study was designed to examine the range of synaptic relationships that CRF terminals make within the PVN. CRF-positive synapses were numerous, particularly in the periventricular zone. The majority of terminals formed axo-dendritic synapses and of these over 85% were the Gray's type II (symmetrical) class. Axo-somatic terminals were also encountered and both parvicellular and magnocellular neurons were innervated. Once again most of the terminals were Gray's type II. Although an innervation of unidentified structures was the most common, CRF synapses onto CRF neurons and dendrites were observed. All CRF/CRF interactions had symmetrical membrane specializations. These studies indicate that CRF could play a prominent role in the modulation of both parvicellular and magnocellular neurons within the paraventricular nucleus, including modulation of its own neurosecretory activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785663     DOI: 10.1159/000125131

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  8 in total

1.  Organization and Integration of the Endocrine System.

Authors:  George P Chrousos
Journal:  Sleep Med Clin       Date:  2007-06

2.  Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.

Authors:  N Laflamme; S Bovetto; D Richard; S Rivest
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 3.  Molecular biology of the regulation of hypothalamic hormones.

Authors:  J M Rondeel; I M Jackson
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

Review 4.  Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.

Authors:  Tsukasa Nozu; Toshikatsu Okumura
Journal:  J Gastroenterol       Date:  2015-05-12       Impact factor: 7.527

5.  Increased expression level of corticotropin-releasing hormone in the amygdala and in the hypothalamus in rats exposed to chronic unpredictable mild stress.

Authors:  Shan-Shan Wang; Xue-Bo Yan; Michel A Hofman; Dick F Swaab; Jiang-Ning Zhou
Journal:  Neurosci Bull       Date:  2010-08       Impact factor: 5.203

Review 6.  Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis.

Authors:  Robert J Handa; Michael J Weiser
Journal:  Front Neuroendocrinol       Date:  2013-11-16       Impact factor: 8.606

7.  Central CRF neurons are not created equal: phenotypic differences in CRF-containing neurons of the rat paraventricular hypothalamus and the bed nucleus of the stria terminalis.

Authors:  Joanna Dabrowska; Rimi Hazra; Ji-Dong Guo; Sarah Dewitt; Donald G Rainnie
Journal:  Front Neurosci       Date:  2013-08-30       Impact factor: 4.677

Review 8.  Nur transcription factors in stress and addiction.

Authors:  Danae Campos-Melo; Danny Galleguillos; Natalia Sánchez; Katia Gysling; María E Andrés
Journal:  Front Mol Neurosci       Date:  2013-12-02       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.